Is IMMUCELL CORP /DE/ (ICCC) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 25.3% / 30% | 6.3% / 30% | 6.4% / 30% | 0.29% / 5% | ✓ HALAL |
| DJIM | 25.3% / 33% | 6.3% / 33% | 6.4% / 33% | 0.29% / 5% | ✓ HALAL |
| MSCI | 33.5% / 33% | 8.3% / 33% | 8.5% / 33% | 0.29% / 5% | ✗ NOT HALAL |
| S&P | 25.3% / 33% | 6.3% / 33% | 6.4% / 33% | 0.29% / 5% | ✓ HALAL |
| FTSE | 33.5% / 33% | 8.3% / 33% | 8.5% / 50% | 0.29% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 41.4% | |
| Operating Margin | -0.8% | |
| Net Margin | -3.8% | |
| Return on Equity (ROE) | -3.6% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $357,903 |
| Free Cash Flow | -$107,822 |
| Total Debt | $15M |
| Debt-to-Equity | 45.7 |
| Total Assets | $45M |
Price & Trading
| Last Close | $6.53 |
| 50-Day MA | $6.40 |
| 200-Day MA | $6.22 |
| Avg Volume | 24K |
| Beta | 0.3 |
|
52-Week Range
$4.52
| |
About IMMUCELL CORP /DE/ (ICCC)
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments: Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.
Purification Calculator
As a halal stock with 0.29% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is IMMUCELL CORP /DE/ (ICCC) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), IMMUCELL CORP /DE/ is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is IMMUCELL CORP /DE/'s debt ratio?
IMMUCELL CORP /DE/'s debt ratio is 25.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 33.5%.
Does IMMUCELL CORP /DE/ require dividend purification?
Yes, IMMUCELL CORP /DE/ has an impermissible income ratio of 0.29%, which means 0.29% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are IMMUCELL CORP /DE/'s key financial metrics?
IMMUCELL CORP /DE/ has a market capitalization of $59M, and revenue of $26M. The company maintains a gross margin of 41.4% and a net margin of -3.8%. Return on equity stands at -3.6%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.